As we stride further into 2025, the pharmacy industry faces a landscape teeming with challenges and opportunities. From tackling drug ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer ...